The Hypoparathyroidism pipeline guide evaluates Hypoparathyroidism (Hormonal Disorders) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type. Main key players of Hypoparathyroidism pipeline are Ascendis Pharma A/S, Chugai Pharmaceutical Co Ltd, Eli Lilly and Company, Entera Bio Ltd, Pharis Biotec GmbH, Shire Plc Hypoparathyroidism is decreased function of the parathyroid glands with underproduction of parathyroid hormone. This leads to low levels of calcium in the blood, often causing cramping and twitching of muscles (involuntary muscle contraction), and several other symptoms. The condition can be inherited, but it is also encountered after thyroid or parathyroid gland surgery, and it can be caused by immune system-related damage as well as a number of rarer causes. The treatment includes artificial form of the hormone that can be administered as replacement, calcium replacement or vitamin. Discount Available at http://www.reportsnreports.com/contacts/discount.aspx?name=1010771 (This report is available at upto 25% Discount till June 02nd 2017.) Hypoparathyroidism - Drug Profiles are hPTH-137, parathyroid hormone, PCO-371, PTH-RM, teriparatide. Hypoparathyroidism - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Hypoparathyroidism (Hormonal Disorders), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Order a copy of this research report at http://www.reportsnreports.com/purchase.aspx?name=1010771
Scope
The pipeline guide provides a snapshot of the global therapeutic landscape of Hypoparathyroidism (Hormonal Disorders). The pipeline guide reviews pipeline therapeutics for Hypoparathyroidism (Hormonal Disorders) by companies and universities/research institutes based on information derived from company and industry-specific sources. The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages. The pipeline guide reviews key companies involved in Hypoparathyroidism (Hormonal Disorders) therapeutics and enlists all their major and minor projects. The pipeline guide evaluates Hypoparathyroidism (Hormonal Disorders) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type. The pipeline guide encapsulates all the dormant and discontinued pipeline projects. The pipeline guide reviews latest news related to pipeline therapeutics for Hypoparathyroidism (Hormonal Disorders)
List of Tables Number of Products under Development for Hypoparathyroidism, H1 2017 Number of Products under Development by Companies, H1 2017 Products under Development by Companies, H1 2017 Number of Products by Stage and Target, H1 2017 Number of Products by Stage and Mechanism of Action, H1 2017 Number of Products by Stage and Route of Administration, H1 2017 Number of Products by Stage and Molecule Type, H1 2017 Hypoparathyroidism - Pipeline by Ascendis Pharma A/S, H1 2017 Hypoparathyroidism - Pipeline by Chugai Pharmaceutical Co Ltd, H1 2017 Hypoparathyroidism - Pipeline by Eli Lilly and Company, H1 2017 Hypoparathyroidism - Pipeline by Entera Bio Ltd, H1 2017 Hypoparathyroidism - Pipeline by Pharis Biotec GmbH, H1 2017 Hypoparathyroidism - Pipeline by Shire Plc, H1 2017 Hypoparathyroidism - Dormant Projects, H1 2017 List of Tables. Tables Content.
About Us: ReportsnReports.com is an online market research reports library of 500,000+ in-depth studies of over 5000 micro markets. Call +1 888 391 5441 with your research requirements or email the details at sales@reportsandreports.com and we would be happy to help you find the business intelligence that you need. ReportsnReports.com offers research studies on agriculture, energy and power, automotive, Semiconductor and Electronics, Manufacturing & Construction, chemicals, environment, medical devices, healthcare, food and beverages, water and much more.